<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Diseases of the Arteries (Atherosclerosis, Arteriosclerosis)</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="cardiovascular-disorders-introduction-and-ccf.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 33.33%;"></div>
                        </div>
                       <span class="progress-text">Lecture 2 of 6</span>
                    </div>
                    <a href="cardiovascular-disorders-coronary-and-pulmonary-disease.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">DISEASES OF THE ARTERIES</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                <!-- START: section-athero-arterio -->
                <section id="athero-arterio" class="content-section" aria-labelledby="section-heading-1">
                    <h2 id="section-heading-1" class="section-heading">
                        <span class="heading-icon"></span>
                        <span class="heading-text">ATHEROSCLEROSIS AND ARTERIOSCLEROSIS</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">ATHEROSCLEROSIS</h3>
                        <p>A disease of the arteries in which fatty plaques develop on their inner walls, eventually obstructing blood flow and interfering with absorption of nutrients</p>
                        
                        <h3 class="subsection-heading">ARTERIOSCLEROSIS</h3>
                        <p>Means hardening of the arteries with loss of elasticity within the medial layer of the walls of small arteries, causing impaired blood supply to the organs and severe elevation of blood pressure (i.e. hypertension)</p>
                        <p>It is associated with atheroma and old age</p>
                        <aside class="callout note" role="note">
                           <p>Although the processes of atherosclerosis and arteriosclerosis differ, rarely does one occur without the other</p>
                        </aside>
                    </div>
                </section>
                <!-- END: section-athero-arterio -->

                <!-- START: section-atherosclerosis -->
                <section id="atherosclerosis" class="content-section" aria-labelledby="section-heading-2">
                    <h2 id="section-heading-2" class="section-heading">
                        <span class="heading-icon"></span>
                        <span class="heading-text">ATHEROSCLEROSIS</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Pathophysiology</h3>
                        <p>It is a disease of the arteries in which fatty plaques develop in the internal layer of the medium and large arteries e.g. the coronary arteries, eventually obstructing them</p>
                        <p>The deposits interfere with absorption of nutrients by the endothelial cells that compose the lining of and protrude into the lumen, obstructing blood flow</p>
                        <p>There is accumulation of smooth muscle cells, fat plaques (atheroma) with lipids, fatty acids, cholesterol, calcium crystals, carbohydrates, blood components and fibrous tissue</p>
                        <p>Secondary changes can occur as a result of arterial dilatation and aneurysm formation</p>

                        <h3 class="subsection-heading">TYPES</h3>
                        <ol>
                            <li><strong>Fatty Streak</strong>
                                <ol type="a">
                                    <li>A yellowish, smooth lesion which does not obstruct blood flow</li>
                                    <li><strong>Histology</strong>
                                        <ol type="i">
                                            <li>Presence of cholesterol, fat deposits within the smooth muscle cells and macrophages in the internal layer of the artery causes them to balloon out and are referred to as "foam cells"</li>
                                            <li>Age incidence - infancy to old age</li>
                                        </ol>
                                    </li>
                                </ol>
                            </li>
                            <li><strong>Raised Fibrous Plaque</strong>
                                <ol type="a">
                                    <li>Is the characteristic lesion of atherosclerosis</li>
                                    <li>It is a localized, yellowish-grey, elevated lump on the inner surface of the artery. It protrudes into the arterial lumen and obstructs blood flow</li>
                                    <li><strong>Histology</strong>
                                        <ol type="i">
                                            <li>Involves:
                                                <ol>
                                                    <li>Proliferation (multiplication) of smooth muscle cells and macrophages</li>
                                                    <li>Intracellular and extracellular fat deposits and</li>
                                                    <li>Accumulation of connective tissue (collagen, elastic fibres)</li>
                                                </ol>
                                            </li>
                                            <li>Defective cells consist of
                                                <ol>
                                                    <li>A fibrous cap / covering (of collagen, etc.)</li>
                                                    <li>A central part with a mass of lipid material (cholesterol), cellular waste and plasma proteins</li>
                                                </ol>
                                            </li>
                                            <li>At autopsy, the centre of large plaques has a thick, yellow liquid atheroma (Greek word for gruel/uji)</li>
                                        </ol>
                                    </li>
                                </ol>
                            </li>
                            <li><strong>Complicated Lesion</strong>
                                <ol type="a">
                                    <li>This is a fibrous cap with any of the following
                                        <ol type="i">
                                            <li>Calcification</li>
                                            <li>Rupture of the plaque</li>
                                            <li>Haemorrhage into the plaque</li>
                                            <li>Thrombus formation</li>
                                        </ol>
                                    </li>
                                    <li>It is associated with signs and symptoms caused by complete occlusion of blood flow to an organ, especially in people with advanced disease</li>
                                    <li>The middle layer also undergoes pressure atrophy (wasting) and loss of elastic tissue, causing sufficient weakness leading to arterial dilatation (aneurysm). If untreated, it can result in fatal rupture and haemorrhage</li>
                                    <li>In smaller arteries, especially in the heart and the brain, the narrowing by plaques accompanied by thrombosis will lead to occlusion, causing myocardial infarction (MI) or cerebrovascular accident (CVA)</li>
                                </ol>
                            </li>
                        </ol>

                        <h3 class="subsection-heading">EFFECTS OF ATHEROSCLEROTIC PLAQUES</h3>
                        <ul>
                            <li>Narrowing the arterial lumen to cause ischaemia</li>
                            <li>Sudden occluding of the lumen by thrombosis, causing infarction</li>
                            <li>Providing a site for thrombosis then embolism</li>
                            <li>Forming an aneurysm, then rupturing</li>
                        </ul>
                        <p><strong>The effects occur most frequently in</strong></p>
                        <ul>
                            <li>The heart</li>
                            <li>The brain</li>
                            <li>The kidneys</li>
                            <li>Lower extremities and</li>
                            <li>Small intestine</li>
                        </ul>
                        
                        <h3 class="subsection-heading">MANAGEMENT</h3>
                        <ul>
                            <li>Bed rest</li>
                            <li>Provide warmth to cold extremities (if partial obstruction)</li>
                            <li>Elevate the feet</li>
                            <li>Moderate regular exercises of the limbs</li>
                            <li>Skin care</li>
                            <li>Low animal fat diet</li>
                            <li><strong>Medication</strong>
                                <ul>
                                    <li><strong>Vasodilators</strong>
                                        <ul>
                                            <li>Pitressin tannate 1 ml (5 units)SC /IM</li>
                                            <li>Pitressin 1 ml (20 units) SC /IM</li>
                                        </ul>
                                    </li>
                                    <li><strong>Antilipemics</strong> to decrease serum lipids (have also a vasodilating effect)
                                        <ul>
                                            <li>Nicotinic acid 1-2 g/X3/day with meals</li>
                                        </ul>
                                    </li>
                                    <li><strong>Digoxin (digitalis)</strong> - <strong>0.125</strong> mg - <strong>0.5</strong> mg
                                        <ul>
                                            <li>Check pulse before administration</li>
                                        </ul>
                                    </li>
                                </ul>
                            </li>
                            <li><strong>Surgical intervention if indicated</strong>
                                <ul>
                                    <li>Amputation in case of gangrene due to thrombosis</li>
                                    <li>Vein grafting</li>
                                    <li>Endarterectomy - surgical removal of atheromas</li>
                                    <li>Pre - and Post - operative care</li>
                                </ul>
                            </li>
                        </ul>
                        <p><strong>On Discharge</strong></p>
                        <ul>
                            <li><strong>Health education on</strong>
                                <ul>
                                    <li>Aeteology</li>
                                    <li>Prevention</li>
                                    <li>Signs / symptoms</li>
                                    <li>Follow up</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: section-atherosclerosis -->

                <!-- START: section-arteriosclerosis-buergers -->
                <section id="arteriosclerosis-buergers" class="content-section" aria-labelledby="section-heading-3">
                    <h2 id="section-heading-3" class="section-heading">
                        <span class="heading-icon"></span>
                        <span class="heading-text">ARTERIOSCLEROSIS (THROMBOANGIITIS) OBLITERANS (BUERGER`S DISEASE)</span>
                    </h2>
                    <div class="content-card">
                        <p>This is partial or complete obstruction of the arteries, especially within the extremities, by atheromatous plaques which reduce the diameter of the vessel</p>
                        <p>The plaques cause irregular surface of the vessel wall, predisposing thrombus formation which further reduces the diameter</p>
                        <p>The obstruction impedes blood flow to the extremities leading to</p>
                        <ul>
                            <li>Ischaemia (if partial) or</li>
                            <li>Infarction (if complete)</li>
                        </ul>

                        <h4 class="subsubsection-heading">Age / Gender</h4>
                        <ul>
                            <li>45-70 years,</li>
                            <li>More frequently in men than women</li>
                        </ul>

                        <h4 class="subsubsection-heading">Predisposing Factors</h4>
                        <ul>
                            <li>Cigarette smoking and tobacco chewing</li>
                            <li>High fat diets</li>
                            <li>Sedentary lifestyle</li>
                            <li>Hypertension</li>
                            <li>Diabetes mellitus</li>
                        </ul>

                        <h4 class="subsubsection-heading">Causes / Aetiology</h4>
                        <ul>
                            <li>Errors in fat metabolism</li>
                            <li>Coagulation defects</li>
                            <li>Heredity</li>
                            <li>Reduced blood supply to arterial wall</li>
                            <li>Stress - related catecholamine (norepinephrine - a neurohormone) which slows the heart rate</li>
                            <li>Chemicals - Tar, nicotine (constricts peripheral vessels and increases force of flow), and carbon monoxide from cigarettes</li>
                            <li>Trauma</li>
                            <li>Viral infections</li>
                        </ul>
                        
                        <h4 class="subsubsection-heading">Pathophysiology</h4>
                        <p>An atherosclerotic plaque forms, causing thickening of the intima, degenerative changes in the middle layer of the artery, resulting in platelet aggregation leading to thrombus formation at the site</p>
                        
                        <h4 class="subsubsection-heading">Commonly Affected Arterial Sites</h4>
                        <ul>
                            <li>Superficial femeral</li>
                            <li>Proximal popliteal</li>
                            <li>Aortoiliac</li>
                            <li>Tibial</li>
                            <li>Peroneal</li>
                        </ul>
                        
                        <h4 class="subsubsection-heading">Compensatory Mechanisms</h4>
                        <p>A network of collateral circulation may develop, allowing the vessels below the obstruction to fill</p>
                        
                        <h4 class="subsubsection-heading">Clinical Manifestations</h4>
                        <p>These result from decreased oxygen supply to the peripheral tissues</p>
                        <ul>
                            <li><strong>Intermittent Claudication</strong>
                                <ul>
                                    <li>Limping caused by interference with blood supply to the legs</li>
                                    <li>The patient complains of cramp-like pain after walking a certain distance, which disappears if he rests at that point</li>
                                    <li>The cramping pain results from the build-up of metabolic wastes within the muscle tissue.
                                        <ul>
                                            <li>An exercising muscle demands more oxygen, but because arterial flow is decreased, less oxygenated blood reaches the tissues.</li>
                                            <li>Waste products of anaerobic metabolism build up in the muscle.</li>
                                            <li>There is local irritation by these toxic wastes, causing the ischaemic pain.</li>
                                            <li>When the patient rests, the metabolites are washed away and the pain goes away.</li>
                                        </ul>
                                    </li>
                                    <li><strong>Mechanism of Intermittent Claudication</strong>
                                        <ol>
                                            <li>Activity / Exercise</li>
                                            <li>Increased tissue oxygen demand</li>
                                            <li>Impaired O<sub>2</sub> supply secondary to obstruction</li>
                                            <li>Shift to anaerobic metabolism</li>
                                            <li>Build-up of metabolic wastes (e.g. Lactic acid)</li>
                                            <li>Local irritation of peripheral nerve endings</li>
                                            <li>Pain in extremity</li>
                                            <li>Rest</li>
                                            <li>Decreased tissue O<sub>2</sub> demand</li>
                                            <li>Return to anaerobic metabolism</li>
                                            <li>Elimination of metabolic wastes</li>
                                            <li>Relief of pain</li>
                                        </ol>
                                    </li>
                                </ul>
                            </li>
                            <li><strong>Resting Pain</strong>
                                <ul>
                                    <li>The pain is described as Burning, Numbness, Tingling of toes</li>
                                    <li>It may be as a result of ischaemic neuritis</li>
                                    <li>It occurs at night and interrupts sleep</li>
                                    <li>It is alleviated by standing or walking</li>
                                </ul>
                            </li>
                            <li><strong>Pallor and redness (mottling) of extremities</strong></li>
                            <li><strong>Gangrene if occlusion has been present for several days</strong>
                                <ul>
                                    <li><strong>Pre-gangrenous state</strong> - Tissue is deep purple and not affected by change of position or pressure</li>
                                    <li><strong>Gangrenous state</strong> - Area looks black, dried and hard</li>
                                    <li>Patient may not be aware as sensation is absent</li>
                                </ul>
                            </li>
                            <li><strong>Skin changes</strong>
                                <ul>
                                    <li>Cool and dry</li>
                                    <li>Smooth, thin and shiny</li>
                                    <li>Reduced or absent hair growth</li>
                                    <li>Nail thickening</li>
                                </ul>
                            </li>
                            <li><strong>Uneven temperature</strong>
                                <ul>
                                    <li>Patient may complain of a "cold foot" which does not change when exposed to warmth</li>
                                </ul>
                            </li>
                            <li><strong>Unequal muscle bulk and tone</strong></li>
                            <li><strong>Peripheral pulses are diminished or absent</strong></li>
                        </ul>
                        
                        <h4 class="subsubsection-heading">Diagnosis</h4>
                        <ul>
                            <li>Segmental systolic pressures are taken using pneumatic (air) cuffs in each arm, thigh, calf and ankle</li>
                            <li>A difference of <strong>20 mmHg</strong> or more between segments indicates occlusion</li>
                        </ul>
                        
                        <h3 class="subsection-heading">MANAGEMENT</h3>
                        <p><strong>Treatment is palliative</strong></p>
                        <p><strong>Aim:</strong> To reduce risk factors to halt progression of the disease</p>
                        <ul>
                            <li>Stopping smoking</li>
                            <li>Exercises especially walking</li>
                            <li>Low fat diet</li>
                            <li><strong>Drugs / Medication</strong>
                                <ul>
                                    <li><strong>Pentoxyfylline (Trental)</strong>
                                        <ul>
                                            <li>Decreases blood viscosity and alleviates ischaemic symptoms</li>
                                            <li>Oral dose: 300 mg - 600 mg daily</li>
                                            <li>IV dose: 100 mg - 150 mg / hr</li>
                                            <li>(Maximum 1.2 g/24 hrs)</li>
                                        </ul>
                                    </li>
                                    <li><strong>Nifedipine (Adalat)</strong>
                                        <ul>
                                            <li>Peripheral vasodilator</li>
                                            <li>Dose: <strong>10 mg - 20 mg</strong> twice / thrice per day</li>
                                        </ul>
                                    </li>
                                    <li><strong>Antilipemics</strong>
                                        <ul>
                                            <li>To slow atherosclerotic process by decreasing serum lipids</li>
                                            <li>Nicotinic acid (Niacin, Nicotinamide)</li>
                                            <li>Oral: <strong>1.0 g – 2.0 g</strong> X 3 / day with meals</li>
                                        </ul>
                                    </li>
                                    <li><strong>Antiplatelets</strong>
                                        <ul>
                                            <li>To decrease risk of platelet aggregation and thrombus formation e.g.</li>
                                            <li>Aspirin <strong>80 mg - 325 mg</strong> daily</li>
                                        </ul>
                                    </li>
                                </ul>
                            </li>
                            <li><strong>Safety and hygiene:</strong>
                                <ul>
                                    <li>To prevent injury and infection of extremities by
                                        <ul>
                                            <li>Treatment of infections</li>
                                            <li>Surgical cleaning of wounds</li>
                                            <li>Post - operative prophylactic antibiotics</li>
                                        </ul>
                                    </li>
                                </ul>
                            </li>
                            <li><strong>Surgery</strong>
                                <ul>
                                    <li><strong>Peripheral arterial bypass surgery</strong>
                                        <ul>
                                            <li>A synthetic graft (Dacron) is anastomosed to a patent arterial source both proximal and distal to the lesion</li>
                                            <li><strong>Complications</strong>
                                                <ul>
                                                    <li>Infection - may lead to death</li>
                                                    <li>Graft failure</li>
                                                    <li>Amputation</li>
                                                </ul>
                                            </li>
                                        </ul>
                                    </li>
                                </ul>
                            </li>
                            <li><strong>Thrombolysis (Dissolution of clots)</strong>
                                <ul>
                                    <li>Anticoagulants (fibrinolytic agents) in severe occlusion and high risk surgery e.g.</li>
                                    <li>Heparin, Warfarin</li>
                                </ul>
                            </li>
                            <li><strong>Percutaneous Transluminal Angioplasty (PTA)</strong>
                                <ul>
                                    <li>A small catheter with an inflatable balloon is passed through the vessel to compress the lesion and widen the lumen, followed by</li>
                                    <li>Anticoagulant therapy</li>
                                </ul>
                            </li>
                        </ul>

                        <h3 class="subsection-heading">Nursing Management</h3>
                        <p><strong>Aim:</strong> To minimize complications</p>
                        <ul>
                            <li>Evaluate and modify activity</li>
                            <li>Medication administration</li>
                            <li>Support lifestyle changes to reduce risk factors</li>
                            <li>In surgery, maintain and monitor peripheral circulation by observing
                                <ul>
                                    <li>Colour</li>
                                    <li>Temperature</li>
                                    <li>Muscle size and symmetry</li>
                                    <li>Skin for
                                        <ul>
                                            <li>Ulceration</li>
                                            <li>Slow healing</li>
                                            <li>Necrosis</li>
                                        </ul>
                                    </li>
                                    <li>Intermittent claudication</li>
                                    <li>Resting pain</li>
                                </ul>
                            </li>
                        </ul>
                        <p><strong>On Discharge</strong></p>
                        <ul>
                            <li>Follow up in cardiac clinic</li>
                        </ul>
                        <p><strong>Prognosis</strong></p>
                        <p>Depends on</p>
                        <ul>
                            <li>Severity and</li>
                            <li>Association with another underlying disease</li>
                        </ul>
                    </div>
                </section>
                <!-- END: section-arteriosclerosis-buergers -->

            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="cardiovascular-disorders-introduction-and-ccf.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 33.33%;"></div>
                        </div>
                       <span class="progress-text">Lecture 2 of 6</span>
                    </div>
                    <a href="cardiovascular-disorders-coronary-and-pulmonary-disease.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>
        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>